Priority dates, work visas, and labor market data
H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
National AverageGrowth
Growth 2021-2024 (Filing Volume)Top Employers
Hiring This Role| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| FibroGen | 3 | $194,161 | $164,674 - $251,326 | 100.0% |
| Orbis Clinical, LLC | 2 | $155,000 | $155,000 - $155,000 | 100.0% |
| GILEAD SCIENCES, INC. | 2 | $137,295 | $123,548 - $151,041 | 100.0% |
| KARYOPHARM THERAPEUTICS, INC. | 1 | $208,000 | $208,000 - $208,000 | 100.0% |
| Kite Pharma Inc. | 1 | $123,898 | $123,898 - $123,898 | 100.0% |
| SYROS PHARMACEUTICALS, INC. | 1 | $161,595 | $161,595 - $161,595 | 0.0% |
| ALPHA CONSULTING CORP. | 1 | $142,230 | $142,230 - $142,230 | 100.0% |
| Worldwide Clinical Trials Holdings, Inc. | 1 | $206,565 | $206,565 - $206,565 | 100.0% |
| BRISTOL MYERS SQUIBB COMPANY | 1 | $149,302 | $149,302 - $149,302 | 100.0% |
| EXELIXIS, INC. | 1 | $173,934 | $173,934 - $173,934 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| Manager | 14 | $166,614 | $123,548 - $251,326 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| San Francisco | CA | 2 | $208,905 |
| Foster City | CA | 2 | $137,295 |
| Tarrytown | NY | 2 | $155,000 |
| East Brunswick | NJ | 1 | $142,230 |
| Alameda | CA | 1 | $173,934 |
| Newton | MA | 1 | $208,000 |
| Princeton | NJ | 1 | $149,302 |
| Santa Monica | CA | 1 | $123,898 |
| New York | NY | 1 | $164,674 |
| Cambridge | MA | 1 | $161,595 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| FY 2021 | 5 | $158,529 | 100.0% |
| FY 2022 | 4 | $162,453 | 100.0% |
| FY 2023 | 3 | $158,524 | 66.7% |
| FY 2024 | 2 | $207,283 | 100.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| FibroGen | 3 | $194,161 | 100.0% |
| Orbis Clinical, LLC | 2 | $155,000 | 100.0% |
| GILEAD SCIENCES, INC. | 2 | $137,295 | 100.0% |
| KARYOPHARM THERAPEUTICS, INC. | 1 | $208,000 | 100.0% |
| Kite Pharma Inc. | 1 | $123,898 | 100.0% |